EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection

Periyanaina Kesika iD, Subramanian Thangaleela, Natarajan Sisubalan iD, Arumugam Radha, Bhagavathi Sundaram Sivamaruthi iD, Chaiyavat Chaiyasut iD

Pathogens · 12.02.2024 · 13 (2) · 164

DOI: 10.3390/pathogens13020164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 12.02.2024. Verfasst von Periyanaina Kesika und 5 weiteren Autor:innen. Beteiligte Einrichtung: Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: NF-kappa B, COVID-19, SARS-CoV-2, Signal Transduction. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Fund 2024, Chaing Mai University, Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 is a global health threat caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is associated with a significant increase in morbidity and mortality. The present review discusses nuclear factor-kappa B (NF-κB) activation and its potential therapeutical role in treating COVID-19. COVID-19 pathogenesis, the major NF-κB pathways, and the involvement of NF-κB in SARS-CoV-2 have been detailed. Specifically, NF-κB activation and its impact on managing COVID-19 has been discussed. As a central player in the immune and inflammatory responses, modulating NF-κB activation could offer a strategic avenue for managing SARS-CoV-2 infection. Understanding the NF-κB pathway’s role could aid in developing treatments against SARS-CoV-2. Further investigations into the intricacies of NF-κB activation are required to reveal effective therapeutic strategies for managing and combating the SARS-CoV-2 infection and COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BCOVID-19SARS-CoV-2Signal TransductionHumansCOVID-19 Drug Treatment

Stichwörter der Autor:innen

COVID-19NF-κBSARS-CoV-2cytokinesinflammation

Substanzen

NF-kappa B

Autor:innen und Institutionen

  • Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Institute of Biotechnology, Department of Medical Biotechnology and Integrative Physiology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai 602105, Tamil Nadu, India.
  • Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli 620024, Tamil Nadu, India.

ORCID-Profile: Periyanaina Kesika, Natarajan Sisubalan, Bhagavathi Sundaram Sivamaruthi, Chaiyavat Chaiyasut

Förderung

  • Fundamental Fund 2024, Chaing Mai University, Thailand

Zitieren

APA

Kesika, P., Thangaleela, S., Sisubalan, N., Radha, A., Sivamaruthi, B. S., & Chaiyasut, C. (2024). The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection. Pathogens, 13(2), 164. https://doi.org/10.3390/pathogens13020164

Vancouver

Kesika P, Thangaleela S, Sisubalan N, Radha A, Sivamaruthi BS, Chaiyasut C. The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection. Pathogens. 2024;13(2):164. doi:10.3390/pathogens13020164

BibTeX
@article{Kesika2024,
  author = {Kesika, Periyanaina and Thangaleela, Subramanian and Sisubalan, Natarajan and Radha, Arumugam and Sivamaruthi, Bhagavathi Sundaram and Chaiyasut, Chaiyavat},
  title = {The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection},
  journal = {Pathogens},
  year = {2024},
  volume = {13},
  number = {2},
  pages = {164},
  doi = {10.3390/pathogens13020164}
}
Kostenlos starten →